Humacyte (HUMA) Operating Margin Growth (1y) (2021 - 2026)
Powered by 
Analysis
Humacyte (HUMA) Operating Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | 798.00 |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | 2.46 Mn |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn | 13,751.00 |
| 4 | Legend Biotech | 3.53 Bn | 2.57 Bn | 251.50 Mn | 2,348.00 |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | -6,012.00 |
| 6 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - | -2.44 Mn |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 375,193.00 |
| 8 | Sarepta Therapeutics | 2.15 Bn | 1.35 Bn | 251.87 Mn | -1,560.00 |
| 9 | Vericel | 1.93 Bn | 1.76 Bn | 56.40 Mn | 377.00 |
| 10 | Humacyte | 133.72 Mn | 133.72 Mn | -825,000.00 | 322,682.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 322,682.00 |
| Mar 31, 2026 | -135,803.00 |
| Sep 30, 2021 | -664,081.00 |